The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment
about
Angiopoietin-like 4 regulates epidermal differentiation.Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in miceAngiopoietin-like 4 interacts with matrix proteins to modulate wound healingAngiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migrationDysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytesNutritional and Hormonal Regulation of Citrate and Carnitine/Acylcarnitine Transporters: Two Mitochondrial Carriers Involved in Fatty Acid MetabolismThe ANGPTL3-4-8 model, a molecular mechanism for triglyceride traffickingProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersObesity, fatty liver disease and intestinal microbiotaIntronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcriptionAngiopoietin-like 4: a decade of researchAngiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsInverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasionDistinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivationANGPTL4 is produced by entero-endocrine cells in the human intestinal tractGenomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Differential regulation and properties of angiopoietin-like proteins 3 and 4Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γCharacterization of genes for beef marbling based on applying gene coexpression network.Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism.PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signalingInduction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways.Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion.Microbial regulation of intestinal radiosensitivity.Bugging the intestinal response to radiation.Angiopoietin-like 4 is over-expressed in rheumatoid arthritis patients: association with pathological bone resorptionHypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4The G0/G1 switch gene 2 is a novel PPAR target gene.Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes.The Peroxisomal 3-keto-acyl-CoA thiolase B Gene Expression Is under the Dual Control of PPARα and HNF4α in the LiverProteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytesIs the gut microbiota a new factor contributing to obesity and its metabolic disorders?Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites
P2860
Q21135146-2892A227-FD09-4073-8EF9-C8E92BC44626Q24523697-2AE5BE64-A096-4F2F-86A5-48439F17F03AQ24626606-4B299E53-106A-4F17-87A5-302287398E35Q24633821-14390197-58FD-4FCB-AA23-D4B0AB8BA0D2Q24675981-FE6E57D1-3A70-4C40-8E9A-30BA319CE534Q26745573-61AF7C55-2032-459A-9DAD-2F5C38D141FCQ26751057-8E477E4E-6B7A-4E0E-97D7-CC146F1314C1Q26752979-C00094D1-4A5D-44C3-B6D6-2A28648671A0Q26997784-3D9E6C00-358C-4356-9486-96AE3AD36D17Q27334496-719FDF6A-8FC8-4748-98B9-6C7D551C6F13Q28263089-3B0ECAA8-DA00-4BD9-9C74-95BC7CB0027FQ28263229-754670DD-6519-4612-8337-AD5E892B18EAQ28280615-1F825E8F-CE8F-4B53-97CF-C2F70DEB4BD4Q28299905-F7BEBA8E-67F4-4FD9-9738-44C1CC2FF040Q28300566-635F981F-C6EF-4DB4-B895-8384D02A04B7Q28476779-BDFD73F0-3575-450D-87B7-744984D11DC8Q28579076-73F340EE-17DE-4307-8C37-EAA01C6A73AFQ30538765-01363458-3FB4-4910-AD50-A41488358D30Q30572266-923E6A12-C805-41FB-AB1C-EFD2C77E5E8CQ33558855-756C3953-BCC0-4F9C-B6B1-685F6258D959Q33594693-814CD5D5-831D-4DB4-89E6-BCF9C7466591Q33625241-752C2CA8-5DD4-4984-B097-EE2D0B9A45C9Q33711961-31E37961-13AD-450F-A3E7-EEAAC6C01371Q33712428-AB258C0D-C876-457F-843D-63C6A82E829FQ33819755-964DDE31-F8BA-4EE3-A2A5-48DD61D73813Q33851239-67E1DBDD-268B-4FB0-BCA9-63D3C1E610C3Q33930212-5F6ED505-4272-4F00-B263-03F2C965B283Q34016116-D814D40F-8F1F-4E4D-B5B3-C0C012CCDC6CQ34302274-9FBD5345-3B5E-410B-9696-DFD5DF6346CDQ34352831-6490DAC5-C57C-4763-8328-06F7CD755967Q34441198-1C350AF1-3D55-4360-88F9-EA7822E8BB7CQ34487240-4C8FB7B0-6D75-4981-B881-DAA1CA93682DQ34490931-0764F582-623E-4BBF-9732-123E3FB0C61AQ34505898-1F31F193-A6D9-4657-82FC-F921E04605DAQ34692490-FCA48039-0673-4733-860A-552E96388C09Q34700517-1A907CAC-37B8-485B-B5A9-4654AB0AF8A7Q34963041-A61E6048-AB14-4BD4-B937-A6E9F70E8C01Q35250426-BD54BE52-E052-428C-AD0D-7F6A9CDEAA60Q35725309-B0E8A8D3-74C2-4DB2-A00C-F4B801F38A9EQ35739204-D0FDA79E-44D0-46CB-8F34-F6322C9DBA15
P2860
The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@ast
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@en
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@nl
type
label
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@ast
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@en
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@nl
prefLabel
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@ast
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@en
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@nl
P2093
P50
P3181
P356
P1476
The direct peroxisome prolifer ...... eased by fenofibrate treatment
@en
P2093
Arjen Bakker
David Patsouris
Fokko Zandbergen
Frank Veenman
Pascal Escher
Robert Kleemann
Walter Wahli
Wolfgang Koenig
P304
34411-34420
P3181
P356
10.1074/JBC.M403058200
P407
P577
2004-06-09T00:00:00Z